MINI FUTURE LONG - MODERNA Stock

Certificat

FE4MB

NLBNPNL2K3T9

Market Closed - Euronext Paris 12:30:02 2024-07-05 pm EDT
4.78 EUR -5.53% Intraday chart for MINI FUTURE LONG - MODERNA
Current month-4.72%
1 month-39.53%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-05 4.85 -4.15%
24-07-04 5.06 +6.75%
24-07-03 4.74 -0.84%
24-07-02 4.78 -1.24%
24-07-01 4.84 -4.91%

Real-time Euronext Paris

Last update July 05, 2024 at 12:30 pm EDT

More quotes

Static data

Product typeWarrant Knock-Out con Stop Loss
Buy / SellCALL
Underlying MODERNA, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
FE4MB
ISINNLBNPNL2K3T9
Date issued 2023-11-07
Strike 64.69 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.53
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 9.67
Lowest since issue 0.6

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
118.3 USD
Average target price
145.9 USD
Spread / Average Target
+23.27%
Consensus
  1. Stock Market
  2. Certificates
  3. FE4MB Certificat